Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHerlev Hospital
About this trial
The aim of the study is to characterize paraffin oil induced granulomatous disease. We will investigate pathogenesis and natural history of paraffin disease. Subsequently, through further translational studies, we intend to identify novel treatments to be tested in future randomized clinical trials.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
previous intramuscular injection of paraffin or other oil
Disqualifiers
none
Trial population
General population
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Number of patients with concentration of ionized calcium in plasma above normal range = Hypercalcemia
Hypercalcemia in plasma (exploratory not intervention study). yes or no and level.
Time frame
at first examination or developed during observation period until 20252
Number of patients with concentration of parathyroid hormone PTH in plasma below normal range
PTH level in plasma indicator of hypercalcemia
Time frame
at first examination or developed during observation period until 2025Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov